The objective of this proposal is to study the role of Erbin in regulation of nicotinic acetylcholine receptor (AChR) synthesis and underlying mechanisms. Neuregulin (NRG) is a polypeptide essential for the maintenance of high concentration of the AChR at the neuromuscular junction (NMJ). It initiates signal cascades by stimulating ErbB protein tyrosine kinases in skeletal muscle cells and thereby activates Erk to induce the transcription ofAChR subunit genes. An important question yet to be addressed is how NRG signaling is regulated so that AChR is maintained at optimal level. We have recently identified Erbin, an ErbB2 interacting protein, which appears to inhibit Erk activation. Based on preliminary results, we hypothesize that Erbin may negatively regulate or switch off NRG-mediated expression of AChR subunit genes. Such regulatory mechanism may be important for preventing AChR from being over-expressed. This proposal will use a combination of molecular, cellular, biochemical, and genetic techniques to define the role of Erbin in NRG-mediated AChR transcription and to determine involved mechanisms. Specifically, we will 1) study the role of Erbin in NRG-mediated transcription of the AChR epsilon-subunit gene; 2) clarify whether Erbin inhibits Ras activation or binds to active Ras to prevent Raf activation; and 3) define structural elements necessary for Erbin inhibition ofNRG-mediated Erk activation. The resulting data will provide a better understanding of how NRG signaling and NRG-induced AChR expression are regulated at cellular levels. Such knowledge will contribute to our understanding of neurological disorders at the NMJ.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS044521-03
Application #
6945226
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Stewart, Randall R
Project Start
2003-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2007-07-31
Support Year
3
Fiscal Year
2005
Total Cost
$237,738
Indirect Cost
Name
Georgia Health Sciences University
Department
Neurology
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Dai, Fangyan; Chang, Chenbei; Lin, Xia et al. (2007) Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain. Mol Cell Biol 27:6183-94
Calin-Jageman, Irina; Yu, Kuai; Hall, Randy A et al. (2007) Erbin enhances voltage-dependent facilitation of Ca(v)1.3 Ca2+ channels through relief of an autoinhibitory domain in the Ca(v)1.3 alpha1 subunit. J Neurosci 27:1374-85
Zhou, Zheng; Immel, David; Xi, Cai-Xia et al. (2006) Regulation of osteoclast function and bone mass by RAGE. J Exp Med 203:1067-80
Xie, Yi; Hong, Yan; Ma, Xiao-Yue et al. (2006) DCC-dependent phospholipase C signaling in netrin-1-induced neurite elongation. J Biol Chem 281:2605-11
Xie, Yi; Ding, Yu-Qiang; Hong, Yan et al. (2005) Phosphatidylinositol transfer protein-alpha in netrin-1-induced PLC signalling and neurite outgrowth. Nat Cell Biol 7:1124-32
Ren, Yuan; Meng, Songshu; Mei, Lin et al. (2004) Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem 279:8497-505
Luo, Zhenge; Wang, Qiang; Dobbins, G Clement et al. (2003) Signaling complexes for postsynaptic differentiation. J Neurocytol 32:697-708
Kim, Chang-Hoon; Xiong, Wen C; Mei, Lin (2003) Regulation of MuSK expression by a novel signaling pathway. J Biol Chem 278:38522-7